EP Patent

EP3500575A4 — CRYSTALLINE FORM OF (S) -7- (1-ACRYLOYLPIPERIDIN-4-YL) -2- (4-PHENOXYPHENYL) -4,5,6,7-TETRA-HYDROPYRAZOLO [1,5-A] PYRIMIDINE-3-CARBOXAMIDE , ITS PREPARATION AND ITS USES

Assigned to BeOne Medicines I GmbH · Expires 2020-04-08 · 6y expired

What this patent protects

Patent listed against Brukinsa.

Drugs covered by this patent

Patent Metadata

Patent number
EP3500575A4
Jurisdiction
EP
Classification
—
Expires
2020-04-08
Drug substance claim
No
Drug product claim
No
Assignee
BeOne Medicines I GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.